tiprankstipranks
Trending News
More News >
Avalo Therapeutics (AVTX)
NASDAQ:AVTX

Avalo Therapeutics (AVTX) Revenue

Compare
1,041 Followers

Avalo Therapeutics Revenue

Avalo Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 192.00K, Increased -56.46%. In the fiscal year ending Dec 31, 2024, Avalo Therapeutics had annual revenue of 441.00K with -77.08% growth.
Revenue (ttm)
192.00K
Revenue Growth
-76.59%
P/S Ratio
645.64
Revenue/Employee
$19,174
Employees
23
Market Cap
$284.73M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
441.00K-1.48M-77.08%
Dec 31, 2023
1.92M-16.13M-89.34%
Dec 31, 2022
18.05M12.65M+234.40%
Dec 31, 2021
5.40M-1.30M-19.42%
Dec 31, 2020
6.70M-51.35K-0.76%
Dec 31, 2019
6.75M-11.58M-63.17%
Dec 31, 2018
18.33M-9.49M-34.11%
Dec 31, 2017
27.81M